Published by Josh White on 6th February 2024
(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.
URL: http://www.digitallook.com/dl/news/story/34071391/...